Overview Financials News + Filings
|
|
Health-Right Discoveries, Inc. > Segments
|
|
| OTC and Prescription Medicine |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Sep-30-20 | Jun-30-20 | Mar-31-20 | Dec-31-19 | Sep-30-19 | Jun-30-19 | Mar-31-19 | Dec-31-18 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 |
| Revenue growth | -45.0% | -56.1% | -65.4% | -55.6% | -39.1% | -50.4% | -54.0% | |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 |
| Gross margin | 30.7% | 30.9% | 33.6% | 36.1% | 24.6% | 29.7% | 24.7% | 20.2% |
| EBITDA | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
| EBITDA margin | 57.7% | 58.9% | 61.3% | 74.7% | 36.5% | 39.2% | 31.5% | 11.3% |
| Depreciation and amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBIT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBIT margin | 32.1% | 30.9% | 30.1% | 47.0% | 18.6% | 23.4% | 18.0% | -4.6% |
| |
| Revenue Mix | 27.1% | 22.9% | 20.0% | 13.2% | 20.4% | 21.2% | 21.2% | 18.3% |
| EBIT Mix | | | | 29.2% | | 44.7% | 20.1% | |
|